Researchers identified four subtypes of ALS, which could lead to more effective, personalized treatments. The study also highlights significant molecular differences between men and women with ALS. A promising drug target, the MAPK signaling pathway, was identified, which could lead to new therapies. These findings bring us closer to understanding and treating this fatal neurodegenerative disease.